HIV gp120 V1/V2 and C2-V3 domains glycoprotein compatibility is required for viral replication

Virus Research

Volumn 79, Issue 1-2, 2001, Pages 91-101

  Chen, Meisheng ^a   Shi, Chaofu ^b   Kalia, Vandana ^b   Tencza, Sarah B ^b   Montelaro, Ronald C ^b   Gupta, Phalguni ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

C2 V3 domains; Glycoprotein compatibility; HIV; V1 V2 domains

Indexed keywords

GLYCOPROTEIN GP 120;

ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; ENVELOPE GENE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; PROTEIN INTERACTION; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; STEREOSPECIFICITY; VIRUS ASSEMBLY; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN;

BINDING SITES; CELL LINE; CELLS, CULTURED; GLYCOPROTEINS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; PEPTIDE FRAGMENTS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0035813035     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(01)00322-7     Document Type: Article

References (44)

1. Impact of natural sequence variation in the V2 region of the envelope protein of human immunodeficiency virus type 1 on syncytium induction: A mutational analysis
2. Use of cryopreserved normal peripheral blood lymphocytes for isolation of human immunodeficiency virus from seropositive men
3. Human immunodeficiency virus isolates from asymptomatic homosexual men and from AIDS patients have ditinct biologic and genetic properties
4. The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism
5. Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: Role of the V3 loop and C4 envelope determinants
6. Survival and recovery of seeded HIV in water and wastewater
7. HIV-1 co-receptors participates in post-entry stages of the virus replication cycle and function in SIV infection
8. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus that evolve in the host alter recognition by neutralizing antibodies
9. Isolation of two infectious molecular clones of HIV-1 with divergent biologic property longitudinally isolated from a seropositive subject
10. Biologic features of HIV that correlate with virulence in the host
11. Viral determinants of human immunodeficiency virus type 1 T cell/macrophage tropism, cytopathogenicity and CD4 antigen modulation
12. Efficient amplifcation using 'megaprimer' by asymmetric polymerase chain reaction
13. Model for intracellular folding of the human immunodeficiency virus type 1 gp120
14. N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure
15. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule
16. Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR
17. Carbohydrates of human immunodeficiency virus. Structures of oligosaccharides linked to the envelope glycoprotein 120
18. High viral load in semen of HIV-1 infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside RT inhibitors
19. Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface
20. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1
21. Presentation of native epitopes in the V1/V2 and V3 regions of human immunodeficiency virus type 1 gp120 by fusion glycoproteins containing isolated gp120 domains
22. Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization
23. Small amino acid sequence changes within the V2 domain can affect the function of a T cell line-tropic human immunodeficiency virus type 1 envelope gp120
24. Prognostic value of human immunodeficiency virus type 1 biological phenotype for rate of CD4 + cell depletion and progression to AIDS
25. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
26. Assignment of intrachain disulfide bonds and chacterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells
27. Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding
28. The viral envelope gene is involved in macrophage tropism of a human immunodeficiency virus type 1 strain isolated from brain tissue
29. Role of protein N- glycosylation in pathogenesis of human immunodeficiency virus type 1
30. Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: Probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop
31. Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1
32. HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp20 outside the CD4-binding domain
33. The effect of combinations of ampligen and zideorudine or deoxyiniosine against human immunodeficiency; viruses in vitro
34. Functional characterization of the V1V2 region of human immunodeficiency virus type 1
35. O-linked glycosylation of retroviral envelope gene products
36. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations
37. Macrophage and T-cell tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene
38. Small amina acid changes in the V3 hypervariable region of gp120 can affect the T cell line and macrophage tropism of human immunodeficiency virus type 1
39. In vivo sequence variability of human immunodeficiency virus type 1 envelope gp120: Association of V2 extension with slow disease progression
40. Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody
41. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: Studies on sequencial HIV isolates
42. Quantification of HIV-1 RNA in plasma: Comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV monitor test
43. Single amino acid substitution in constant region 1 or 4 of gp120 causes the phenotype of a human immunodeficiency virus type 1 variant with mutations in hypervariable regions 1 and 2 to revert
44. The antigenic structure of the HIV gp120 envelope glycoprotein